Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality [Imaging Tests (Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Capsule Endoscopy, and Others), and Stool Based Tests [Faecal Immunochemical Test (FIT), Guaiac-based Faecal Occult Blood Test (gFOBT), and Stool DNA Test)] and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)
The colorectal cancer diagnostics market size is expected to grow from US$ 10.37 billion in 2022 to US$ 16.99 billion by 2028; it is estimated to record a CAGR of 8.7% from 2023 to 2028.
The colorectal cancer diagnostics market growth is attributed to the increasing prevalence of colorectal cancer and launches of new product.
Colorectal cancer diagnostics refers to the tools, kits, and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on which the treatment is provided to the patient.
March is marked as the National Colorectal Awareness Month in the US. It is dedicated to encouraging patients, survivors, and caregivers to share their stories, advocate for colorectal cancer prevention, and inform others about the importance of early detection. In 2019, the Health Colorectal Cancer Awareness Campaign was launched at the University of California (UCLA) as the first system-wide cancer awareness and prevention effort. The campaign is run as a health leadership commitment to increase awareness about colorectal cancer screening and other related aspects in the UCLA health patient and staff communities, and in medically underserved populations in the greater Los Angeles area. This multifaceted campaign includes public awareness events, Dress in Blue Day, patient and provider education, patient-directed educational videos, community lectures, radio and media appearances, employee wellness and nutrition sessions, and social media promotions. The campaign format was changed slightly in March 2020 due to the COVID-19 pandemic; it provided virtual screening and awareness messages and evolved to include a stronger focus on stool testing to allow patients access to home screening. Owing to such efforts, awareness of colorectal cancer screening is rising in the US, and the screening rates have reached 60% of the country’s population which in turn driving the colorectal cancer diagnostics market growth.
Further, a mass colorectal cancer screening program was conducted in Guangzhou, China, during 2015–2017. It used public media and mobile short message service (SMS) reminders to invite residents aged 50–74 to the screening program. March is European Colorectal Cancer Awareness Month (ECCAM). Further, the American Society for Gastrointestinal Endoscopy has started a campaign to raise awareness about the potentially life-saving benefits of colonoscopy procedures and the importance of keeping up to date with screening.
The use of AI technology in diagnosing and treating several types of cancer, especially colorectal cancer, is now gaining substantial attention. Various AI-supporting systems are available for personalized and novel strategies for managing colorectal cancer. In endoscopy, AI broadly relates to a computer vision technology, allowing computers to “see” and interpret visual content. Through machine learning processes and deep learning, AI systems can be trained to recognize “normal” characteristics by linking gold standards to suitable images. Using computer vision for lesion detection will be the first application of AI in gastroenterology. It would help improve the quality of endoscopy practices in finding and recognizing polyps on colonoscopy.
Thus, the growing awareness about the effects of colorectal cancer on the quality of life and adoption of AI for colorectal cancer imaging tests would trigger the adoption of colonoscopy diagnostic procedures during the forecast period, thus offering lucrative opportunities to the colorectal cancer diagnostics market growth.
End User -Based Insights
Based on end user, the colorectal cancer diagnostics market is categorized into hospitals, diagnostic laboratories, cancer research institutes, and others. In 2022, the hospitals segment accounted for the largest market share, and it is anticipated to register the highest CAGR during the forecast period. The adoption of advanced technologies in hospitals, an increasing number of screening tests performed in hospital settings, advancing healthcare infrastructure in emerging markets, rising healthcare expenditure, lucrative reimbursement policies, and burgeoning emphasis on better patient outcomes are factors contributing to the growth of the colorectal cancer diagnostics market for the hospital segment. The colonoscopy department of the Asian Institute of Gastroenterology, which appoints experts in the field, performs one of the most significant numbers of colonoscopies annually in the world (more than 10,000 procedures per year). These facilities (hospitals) provide appropriate patient care and monitoring after the procedures. The treatment of colorectal cancer follows a multidisciplinary approach wherein a team of colorectal surgeons, oncologists, radiologists, pathologists, and specialist nurses provide integrated care. Surgery is the mainstay of the colorectal cancer treatment. For example, surgeons at Apollo Hospitals, Chennai, India, perform minimally invasive robotic surgeries for treating colorectal cancer patients. Lower pain, quicker recovery, fewer complications, and excellent cancer cure rates are among the significant advantages of minimally invasive surgeries. Therefore, all the above mentioned factors are expected to promote the growth of colorectal cancer diagnostics market in the coming years.
The American Society of Clinical Oncology, European Cancer Information System, and International Agency for Research on Cancer are among the primary and secondary sources referred to while preparing the colorectal cancer diagnostics market report.
The colorectal cancer diagnostics market growth is attributed to the increasing prevalence of colorectal cancer and launches of new product.
Colorectal cancer diagnostics refers to the tools, kits, and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on which the treatment is provided to the patient.
March is marked as the National Colorectal Awareness Month in the US. It is dedicated to encouraging patients, survivors, and caregivers to share their stories, advocate for colorectal cancer prevention, and inform others about the importance of early detection. In 2019, the Health Colorectal Cancer Awareness Campaign was launched at the University of California (UCLA) as the first system-wide cancer awareness and prevention effort. The campaign is run as a health leadership commitment to increase awareness about colorectal cancer screening and other related aspects in the UCLA health patient and staff communities, and in medically underserved populations in the greater Los Angeles area. This multifaceted campaign includes public awareness events, Dress in Blue Day, patient and provider education, patient-directed educational videos, community lectures, radio and media appearances, employee wellness and nutrition sessions, and social media promotions. The campaign format was changed slightly in March 2020 due to the COVID-19 pandemic; it provided virtual screening and awareness messages and evolved to include a stronger focus on stool testing to allow patients access to home screening. Owing to such efforts, awareness of colorectal cancer screening is rising in the US, and the screening rates have reached 60% of the country’s population which in turn driving the colorectal cancer diagnostics market growth.
Further, a mass colorectal cancer screening program was conducted in Guangzhou, China, during 2015–2017. It used public media and mobile short message service (SMS) reminders to invite residents aged 50–74 to the screening program. March is European Colorectal Cancer Awareness Month (ECCAM). Further, the American Society for Gastrointestinal Endoscopy has started a campaign to raise awareness about the potentially life-saving benefits of colonoscopy procedures and the importance of keeping up to date with screening.
The use of AI technology in diagnosing and treating several types of cancer, especially colorectal cancer, is now gaining substantial attention. Various AI-supporting systems are available for personalized and novel strategies for managing colorectal cancer. In endoscopy, AI broadly relates to a computer vision technology, allowing computers to “see” and interpret visual content. Through machine learning processes and deep learning, AI systems can be trained to recognize “normal” characteristics by linking gold standards to suitable images. Using computer vision for lesion detection will be the first application of AI in gastroenterology. It would help improve the quality of endoscopy practices in finding and recognizing polyps on colonoscopy.
Thus, the growing awareness about the effects of colorectal cancer on the quality of life and adoption of AI for colorectal cancer imaging tests would trigger the adoption of colonoscopy diagnostic procedures during the forecast period, thus offering lucrative opportunities to the colorectal cancer diagnostics market growth.
End User -Based Insights
Based on end user, the colorectal cancer diagnostics market is categorized into hospitals, diagnostic laboratories, cancer research institutes, and others. In 2022, the hospitals segment accounted for the largest market share, and it is anticipated to register the highest CAGR during the forecast period. The adoption of advanced technologies in hospitals, an increasing number of screening tests performed in hospital settings, advancing healthcare infrastructure in emerging markets, rising healthcare expenditure, lucrative reimbursement policies, and burgeoning emphasis on better patient outcomes are factors contributing to the growth of the colorectal cancer diagnostics market for the hospital segment. The colonoscopy department of the Asian Institute of Gastroenterology, which appoints experts in the field, performs one of the most significant numbers of colonoscopies annually in the world (more than 10,000 procedures per year). These facilities (hospitals) provide appropriate patient care and monitoring after the procedures. The treatment of colorectal cancer follows a multidisciplinary approach wherein a team of colorectal surgeons, oncologists, radiologists, pathologists, and specialist nurses provide integrated care. Surgery is the mainstay of the colorectal cancer treatment. For example, surgeons at Apollo Hospitals, Chennai, India, perform minimally invasive robotic surgeries for treating colorectal cancer patients. Lower pain, quicker recovery, fewer complications, and excellent cancer cure rates are among the significant advantages of minimally invasive surgeries. Therefore, all the above mentioned factors are expected to promote the growth of colorectal cancer diagnostics market in the coming years.
The American Society of Clinical Oncology, European Cancer Information System, and International Agency for Research on Cancer are among the primary and secondary sources referred to while preparing the colorectal cancer diagnostics market report.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Colorectal Cancer Diagnostics Market – by Modality
1.3.2 Global Colorectal Cancer Diagnostics Market – by End User
1.3.3 Global Colorectal Cancer Diagnostics Market – by Geography
2. COLORECTAL CANCER DIAGNOSTICS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. COLORECTAL CANCER DIAGNOSTICS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South and Central America PEST Analysis
4.2.5 Middle East and Africa PEST Analysis
4.3 Expert’s Opinion
5. COLORECTAL CANCER DIAGNOSTICS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 Launches of New Products
5.2 Key Restraints
5.2.1 Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)
5.3 Opportunities
5.3.1 Growing Awareness of Colorectal Cancer
5.4 Future Trends
5.4.1 Artificial Intelligence in Colonoscopy
5.5 Impact Analysis
6. COLORECTAL CANCER DIAGNOSTICS MARKET – GLOBAL ANALYSIS
6.1 Global Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis
6.2 Global Colorectal Cancer Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2028 – BY MODALITY
7.1 Overview
7.2 Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
7.3 Stool Based Tests
7.3.1 Overview
7.3.2 Stool Based Tests: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Faecal Immunochemical Test (FIT)
7.3.3.1 Overview
7.3.3.2 Faecal Immunochemical Test (FIT): Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Guaiac-based Faecal Occult Blood Test (gFOBT)
7.3.4.1 Overview
7.3.4.2 Guaiac-based Faecal Occult Blood Test (gFOBT): Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Stool DNA Test
7.3.5.1 Overview
7.3.5.2 Stool DNA Test: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
7.4.1 Overview
7.4.2 Imaging Tests: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Colonoscopy
7.4.3.1 Overview
7.4.3.2 Colonoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 CT Colonography
7.4.4.1 Overview
7.4.4.2 CT Colonography: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Flexible Sigmoidoscopy
7.4.5.1 Overview
7.4.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Capsule Endoscopy
7.4.6.1 Overview
7.4.6.2 Capsule Endoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.7 Others
7.4.7.1 Overview
7.4.7.2 Others: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
8.1 Overview
8.2 Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer Research Institutes
8.5.1 Overview
8.5.2 Cancer Research Institutes: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2028 – GEOGRAPHIC ANALYSIS
9.1 North America: Colorectal Cancer Diagnostics Market
9.1.1 Overview
9.1.2 North America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.3.1 North America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.3.2 North America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.4 North America: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.4.1 US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1.1 Overview
9.1.4.1.2 US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1.3 US: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.4.1.3.1 US: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.4.1.3.2 US: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.4.1.4 US: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.4.2 Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.2.1 Overview
9.1.4.2.2 Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.2.3 Canada: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.4.2.3.1 Canada: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.4.2.3.2 Canada: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.4.2.4 Canada: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.4.3 Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.1 Overview
9.1.4.3.2 Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.3 Mexico: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.4.3.3.1 Mexico: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.4.3.3.2 Mexico: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modalitys, 2020–2028 (US$ Million)
9.1.4.3.4 Mexico: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2 Europe: Colorectal Cancer Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.3.1 Europe: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.3.2 Europe: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.4 Europe: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5 Europe: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
9.2.5.1 Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.1.3.1 Germany: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.1.3.2 Germany: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.1.4 Germany: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.2 UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 UK: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.2.3.1 UK: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.2.3.2 UK: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.2.4 UK: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.3 France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 France: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.3.3.1 France: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.3.3.2 France: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.3.4 France: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.4 Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.4.3.1 Italy: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.4.3.2 Italy: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.4.4 Italy: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.5 Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.5.3.1 Spain: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.5.3.2 Spain: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.5.4 Spain: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.6 Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.6.3.1 Rest of Europe: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.6.3.2 Rest of Europe: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3 Asia Pacific: Colorectal Cancer Diagnostics Market
9.3.1 Overview
9.3.2 Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia Pacific: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.3.1 Asia Pacific: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.3.2 Asia Pacific: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4 Asia Pacific: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.1 China: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.1.1 Overview
9.3.4.1.2 China: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.1.3 China: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.1.3.1 China: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.1.3.2 China: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.1.4 China: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.2 Japan: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.2.1 Overview
9.3.4.2.2 Japan: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.2.3 Japan: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.2.3.1 Japan: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.2.3.2 Japan: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.2.4 Japan: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.3 India: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.3.1 Overview
9.3.4.3.2 India: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.3.3 India: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.3.3.1 India: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.3.3.2 India: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.3.4 India: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.4 Australia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.4.1 Overview
9.3.4.4.2 Australia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.4.3 Australia: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.4.3.1 Australia: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.4.3.2 Australia: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.4.4 Australia: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.5 South Korea: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.5.1 Overview
9.3.4.5.2 South Korea: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.5.3 South Korea: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.5.3.1 South Korea: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.5.3.2 South Korea: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.5.4 South Korea: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.6 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.6.1 Overview
9.3.4.6.2 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.6.3 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.6.3.1 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.6.3.2 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.6.4 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4 Middle East & Africa Colorectal Cancer Diagnostics Market
9.4.1 Overview
9.4.2 Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.3 Middle East & Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.3.1 Middle East & Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.3.2 Middle East & Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4 Middle East & Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.1 Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.1.1 Overview
9.4.4.1.2 Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.1.3 Saudi Arabia: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.1.3.1 Saudi Arabia: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.1.3.2 Saudi Arabia: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.1.4 Saudi Arabia Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.2 South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.2.1 Overview
9.4.4.2.2 South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.2.3 South Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.2.3.1 South Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.2.3.2 South Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.2.4 South Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.3 UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.3.1 Overview
9.4.4.3.2 UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.3.3 UAE: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.3.3.1 UAE: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.3.3.2 UAE: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.3.4 UAE Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.4 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.4.1 Overview
9.4.4.4.2 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.4.3 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.4.3.1 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.4.3.2 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.4.4 Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5 South & Central America Colorectal Cancer Diagnostics Market
9.5.1 Overview
9.5.2 South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.3 South & Central America: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.3.1 South & Central America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.3.2 South & Central America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.5.4 South & Central America: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5.5 South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
9.5.5.1 Brazil: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.1 Overview
9.5.5.1.2 Brazil: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.3 Brazil: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.5.1.3.1 Brazil: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.5.1.3.2 Brazil: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.5.5.1.4 Brazil: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5.5.2 Argentina: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.1 Overview
9.5.5.2.2 Argentina: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.3 Argentina: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.5.2.3.1 Argentina: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.5.2.3.2 Argentina: Colorectal Cancer Diagnostics Market, For Stool-Based Tests, 2020–2028 (US$ Million)
9.5.5.2.4 Argentina: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5.5.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.5.3.3.1 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.5.3.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.5.5.3.4 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
10. IMPACT OF COVID-19 PANDEMIC ON COLORECTAL CANCER DIAGNOSTICS MARKET
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET–INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Colorectal Cancer Diagnostics Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Medtronic Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Illumina Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Clinical Genomics Technologies Pty Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 EDP Biotech Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Epigenomics AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Quest Diagnostics Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novigenix SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Siemens Healthineers AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Bruker Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Eiken Chemical Co., Ltd.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Colorectal Cancer Diagnostics Market – by Modality
1.3.2 Global Colorectal Cancer Diagnostics Market – by End User
1.3.3 Global Colorectal Cancer Diagnostics Market – by Geography
2. COLORECTAL CANCER DIAGNOSTICS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. COLORECTAL CANCER DIAGNOSTICS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South and Central America PEST Analysis
4.2.5 Middle East and Africa PEST Analysis
4.3 Expert’s Opinion
5. COLORECTAL CANCER DIAGNOSTICS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 Launches of New Products
5.2 Key Restraints
5.2.1 Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)
5.3 Opportunities
5.3.1 Growing Awareness of Colorectal Cancer
5.4 Future Trends
5.4.1 Artificial Intelligence in Colonoscopy
5.5 Impact Analysis
6. COLORECTAL CANCER DIAGNOSTICS MARKET – GLOBAL ANALYSIS
6.1 Global Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis
6.2 Global Colorectal Cancer Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2028 – BY MODALITY
7.1 Overview
7.2 Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
7.3 Stool Based Tests
7.3.1 Overview
7.3.2 Stool Based Tests: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Faecal Immunochemical Test (FIT)
7.3.3.1 Overview
7.3.3.2 Faecal Immunochemical Test (FIT): Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Guaiac-based Faecal Occult Blood Test (gFOBT)
7.3.4.1 Overview
7.3.4.2 Guaiac-based Faecal Occult Blood Test (gFOBT): Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Stool DNA Test
7.3.5.1 Overview
7.3.5.2 Stool DNA Test: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
7.4.1 Overview
7.4.2 Imaging Tests: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Colonoscopy
7.4.3.1 Overview
7.4.3.2 Colonoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 CT Colonography
7.4.4.1 Overview
7.4.4.2 CT Colonography: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Flexible Sigmoidoscopy
7.4.5.1 Overview
7.4.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Capsule Endoscopy
7.4.6.1 Overview
7.4.6.2 Capsule Endoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.7 Others
7.4.7.1 Overview
7.4.7.2 Others: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
8.1 Overview
8.2 Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer Research Institutes
8.5.1 Overview
8.5.2 Cancer Research Institutes: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2028 – GEOGRAPHIC ANALYSIS
9.1 North America: Colorectal Cancer Diagnostics Market
9.1.1 Overview
9.1.2 North America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.3.1 North America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.3.2 North America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.4 North America: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.4.1 US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1.1 Overview
9.1.4.1.2 US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1.3 US: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.4.1.3.1 US: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.4.1.3.2 US: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.4.1.4 US: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.4.2 Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.2.1 Overview
9.1.4.2.2 Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.2.3 Canada: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.4.2.3.1 Canada: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.4.2.3.2 Canada: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.4.2.4 Canada: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.4.3 Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.1 Overview
9.1.4.3.2 Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.3 Mexico: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.4.3.3.1 Mexico: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.4.3.3.2 Mexico: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modalitys, 2020–2028 (US$ Million)
9.1.4.3.4 Mexico: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2 Europe: Colorectal Cancer Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.3.1 Europe: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.3.2 Europe: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.4 Europe: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5 Europe: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
9.2.5.1 Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.1.3.1 Germany: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.1.3.2 Germany: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.1.4 Germany: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.2 UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 UK: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.2.3.1 UK: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.2.3.2 UK: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.2.4 UK: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.3 France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 France: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.3.3.1 France: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.3.3.2 France: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.3.4 France: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.4 Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.4.3.1 Italy: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.4.3.2 Italy: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.4.4 Italy: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.5 Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.5.3.1 Spain: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.5.3.2 Spain: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.5.4 Spain: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.6 Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.6.3.1 Rest of Europe: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.6.3.2 Rest of Europe: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3 Asia Pacific: Colorectal Cancer Diagnostics Market
9.3.1 Overview
9.3.2 Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia Pacific: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.3.1 Asia Pacific: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.3.2 Asia Pacific: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4 Asia Pacific: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.1 China: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.1.1 Overview
9.3.4.1.2 China: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.1.3 China: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.1.3.1 China: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.1.3.2 China: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.1.4 China: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.2 Japan: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.2.1 Overview
9.3.4.2.2 Japan: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.2.3 Japan: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.2.3.1 Japan: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.2.3.2 Japan: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.2.4 Japan: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.3 India: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.3.1 Overview
9.3.4.3.2 India: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.3.3 India: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.3.3.1 India: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.3.3.2 India: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.3.4 India: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.4 Australia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.4.1 Overview
9.3.4.4.2 Australia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.4.3 Australia: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.4.3.1 Australia: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.4.3.2 Australia: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.4.4 Australia: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.5 South Korea: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.5.1 Overview
9.3.4.5.2 South Korea: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.5.3 South Korea: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.5.3.1 South Korea: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.5.3.2 South Korea: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.5.4 South Korea: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.6 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.6.1 Overview
9.3.4.6.2 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.6.3 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.6.3.1 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.6.3.2 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.6.4 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4 Middle East & Africa Colorectal Cancer Diagnostics Market
9.4.1 Overview
9.4.2 Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.3 Middle East & Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.3.1 Middle East & Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.3.2 Middle East & Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4 Middle East & Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.1 Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.1.1 Overview
9.4.4.1.2 Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.1.3 Saudi Arabia: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.1.3.1 Saudi Arabia: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.1.3.2 Saudi Arabia: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.1.4 Saudi Arabia Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.2 South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.2.1 Overview
9.4.4.2.2 South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.2.3 South Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.2.3.1 South Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.2.3.2 South Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.2.4 South Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.3 UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.3.1 Overview
9.4.4.3.2 UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.3.3 UAE: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.3.3.1 UAE: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.3.3.2 UAE: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.3.4 UAE Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.4 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.4.1 Overview
9.4.4.4.2 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.4.3 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.4.3.1 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.4.3.2 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.4.4 Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5 South & Central America Colorectal Cancer Diagnostics Market
9.5.1 Overview
9.5.2 South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.3 South & Central America: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.3.1 South & Central America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.3.2 South & Central America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.5.4 South & Central America: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5.5 South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
9.5.5.1 Brazil: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.1 Overview
9.5.5.1.2 Brazil: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.3 Brazil: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.5.1.3.1 Brazil: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.5.1.3.2 Brazil: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.5.5.1.4 Brazil: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5.5.2 Argentina: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.1 Overview
9.5.5.2.2 Argentina: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.3 Argentina: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.5.2.3.1 Argentina: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.5.2.3.2 Argentina: Colorectal Cancer Diagnostics Market, For Stool-Based Tests, 2020–2028 (US$ Million)
9.5.5.2.4 Argentina: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5.5.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.5.3.3.1 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.5.3.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.5.5.3.4 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
10. IMPACT OF COVID-19 PANDEMIC ON COLORECTAL CANCER DIAGNOSTICS MARKET
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET–INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Colorectal Cancer Diagnostics Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Medtronic Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Illumina Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Clinical Genomics Technologies Pty Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 EDP Biotech Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Epigenomics AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Quest Diagnostics Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novigenix SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Siemens Healthineers AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Bruker Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Eiken Chemical Co., Ltd.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modalitys– Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Screening approach for colorectal cancer followed in Germany is mentioned in the given Table:
Table 22. Germany Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. UK Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 27. UK Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 28. UK Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 29. UK Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 30. France Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 31. France Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 32. France Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 33. France Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 37. Italy Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 41. Spain Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 49. Asia Pacific Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 50. China Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 51. China Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 52. China Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 53. China Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 54. Japan Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 57. Japan Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 58. India Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 59. India Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 60. India Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 61. India Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 62. Australia Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 63. Australia Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 64. Australia Colorectal Cancer Diagn
Table 1. North America Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modalitys– Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Screening approach for colorectal cancer followed in Germany is mentioned in the given Table:
Table 22. Germany Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. UK Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 27. UK Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 28. UK Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 29. UK Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 30. France Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 31. France Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 32. France Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 33. France Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 37. Italy Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 41. Spain Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 49. Asia Pacific Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 50. China Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 51. China Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 52. China Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 53. China Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 54. Japan Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 57. Japan Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 58. India Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 59. India Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 60. India Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 61. India Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 62. Australia Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 63. Australia Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 64. Australia Colorectal Cancer Diagn
